Pathway Signature and Cellular Differentiation in Clear Cell Renal Cell Carcinoma-Reference-Cited by-同舟云学术

Pathway Signature and Cellular Differentiation in Clear Cell Renal Cell Carcinoma

Published:2010-05-18 Issue:5 Volume:5 Page:e10696
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Tun Han W.,Marlow Laura A.,von Roemeling Christina A.,Cooper Simon J.,Kreinest Pamela,Wu Kevin,Luxon Bruce A.,Sinha Mala,Anastasiadis Panos Z.,Copland John A.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference69 articles.

1. Cancer Statistics, 2009.;A Jemal;CA Cancer J Clin,2009

2. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma.;JC Cheville;Am J Surg Pathol,2003

3. Tumors of the kidney.,2004

4. Differential diagnosis between monomorphic clear cell adenocarcinoma of salivary glands and renal (clear) cell carcinoma.;RB Rezende;Am J Surg Pathol,1999

5. Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma.;M Yao;J Pathol,2005

Cited by 148 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TFCP2L1 drives stemness and enhances their resistance to Sorafenib treatment by modulating the NANOG/STAT3 pathway in hepatocellular carcinoma;Oncogenesis;2024-09-12

2. Epithelial-mesenchymal transition associated markers in sarcomatoid transformation of clear cell renal cell carcinoma;Experimental and Molecular Pathology;2024-08

3. CLEC18A interacts with sulfated GAGs and controls clear cell renal cell carcinoma progression;2024-07-10

4. Altered expression spectrum and target gene prediction of tRNA-derived small RNAs in clear cell renal cell carcinoma;2024-05-31

5. TFCP2L1, a potential differentiation regulator, predicts favorable prognosis and dampens thyroid cancer progression;Journal of Endocrinological Investigation;2024-05-16